COSIMO – patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study

被引：0
|
作者：
Alexander T. Cohen
Anthony Maraveyas
Jan Beyer-Westendorf
Agnes Y. Y. Lee
Lorenzo G. Mantovani
Miriam Bach
机构：
[1] King’s College London,Department of Haematological Medicine, Guys and St Thomas’ NHS Foundation Trust
[2] Castle Hill Hospital,Joint Centre for Cancer Studies, Hull York Medical School, QCOH
[3] University Hospital “Carl Gustav Carus” Dresden,Thrombosis Research Unit, Department of Medicine I, Division Hematology
[4] Kings College London,Kings Thrombosis Service, Department of Haematology
[5] University of British Columbia,Division of Hematology
[6] British Columbia Cancer Agency,CESP
[7] University of Milan Bicocca,Center for Public Health Research
[8] Bayer AG,undefined
来源：
Thrombosis Journal | / 16卷
关键词：
Active cancer; Health-related quality of life; Low molecular weight heparin; Patient preference; Recurrent venous thromboembolism; Rivaroxaban; Vitamin K antagonist;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] COSIMO - patients with active cancer changing to rivaroxaban for the treatment and prevention of recurrent venous thromboembolism: a non-interventional study
    Cohen, Alexander T.
    Maraveyas, Anthony
    Beyer-Westendorf, Jan
    Lee, Agnes Y. Y.
    Mantovani, Lorenzo G.
    Bach, Miriam
    THROMBOSIS JOURNAL, 2018, 16
  • [2] Treatment of venous thromboembolism in ambulatory cancer patients in Germany - a prospective non-interventional study
    Matzdorff, A.
    Schilling, H.
    Ledig, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 217 - 217
  • [3] Treatment of Venous Thromboembolism in Ambulatory Cancer Patients in Germany: A Prospective Non-Interventional Study
    Matzdorff, Axel
    Schilling, Holger
    Ledig, Bettina
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (04) : 174 - 180
  • [4] Patient-reported outcomes associated with changing to rivaroxaban for the treatment of cancer-associated venous thromboembolism - The COSIMO study
    Cohen, Alexander T.
    Maraveyas, Anthony
    Beyer-Westendorf, Jan
    Lee, Agnes Y. Y.
    Folkerts, Kerstin
    Abdelgawwad, Khaled
    De Sanctis, Yoriko
    Fatoba, Samuel
    Bamber, Luke
    Bach, Miriam
    Mantovani, Lorenzo G.
    THROMBOSIS RESEARCH, 2021, 206 : 1 - 4
  • [5] XAMOS: A non-interventional study of rivaroxaban in the prophylaxis of venous thromboembolism after hip or knee surgery
    Turpie, A. G. G.
    Jamal, W.
    Schmidt, A.
    Lassen, M.
    Mantovani, L.
    Kreutz, R.
    Haas, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 961 - 961
  • [6] RIVAROXABAN VERSUS WARFARIN FOR TREATMENT AND PREVENTION OF RECURRENT VENOUS THROMBOEMBOLISM IN AFRICAN AMERICAN PATIENTS
    Costa, Olivia S.
    Thompson, Stanley
    Ashton, Veronica
    Palladino, Michael
    Bunz, Thomas J.
    Coleman, Craig I.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S261 - S261
  • [7] Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients—a prospective interventional study
    Shigeki Takai
    Naohiko Nakanishi
    Isao Yokota
    Kojiro Imai
    Ayumu Yamada
    Takanori Kawasaki
    Takeru Kasahara
    Takashi Okada
    Takahisa Sawada
    Satoaki Matoba
    Scientific Reports, 12 (1)
  • [8] Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban
    Bauersachs, Rupert
    Khorana, Alok A.
    Lee, Agnes Y. Y.
    Soff, Gerald
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (04) : 532 - 549
  • [9] German hematologists/oncologists' practice patterns for prophylaxis and treatment of venous thromboembolism in cancer patients - first results of a non-interventional study
    Matzdorff, A.
    Ledig, B.
    Stuecker, M.
    Riess, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 216 - 216
  • [10] Clot-regression effects of rivaroxaban in venous thromboembolism treatment in cancer patients-a prospective interventional study
    Takai, Shigeki
    Nakanishi, Naohiko
    Yokota, Isao
    Imai, Kojiro
    Yamada, Ayumu
    Kawasaki, Takanori
    Kasahara, Takeru
    Okada, Takashi
    Sawada, Takahisa
    Matoba, Satoaki
    SCIENTIFIC REPORTS, 2022, 12 (01):
12345